Furthermore, we confirmed the significant CD8+T-cell stimulatory function of tumour-infiltrated CD103+ DCs in PAK4 inhibitor-treated mice compared with that in non-treated mice via an in vitro T-cell proliferation assay. Here, PAK4 is linked to neoplasm.